Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bernard

Showing results (471-480 of 650) with videos related to

Pageof 65
Sort By:
JAMA|February 24, 2016
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Mervyn Singer, Clifford S Deutschman, Christopher Warren Seymour, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Trials|April 7, 2019
The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trialDavid N Hager, Michael H Hooper, Gordon R Bernard, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2021
Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical TrialJonathan D Casey, Erin M Vaughan, Bradley D Lloyd, et al.
BMJ Open|May 5, 2018
Measuring outcome differences associated with STEMI screening and diagnostic performance: a multicentred retrospective cohort study protocolMaame Yaa A B Yiadom, Bryn E Mumma, Christopher W Baugh, et al.
Trials|December 6, 2019
Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trialChristopher J Lindsell, Anna McGlothlin, Samuel Nwosu, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Clinical Pharmacology and Therapeutics|May 17, 2012
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT projectJ M Pulley, J C Denny, J F Peterson, et al.
JAMA Internal Medicine|April 18, 2022
Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled TrialEdward Tang Qian, Cheryl L Gatto, Olga Amusina, et al.
Trials|April 23, 2020
In response: Letter on update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocolChristopher J Lindsell, Anna McGlothlin, Samuel Nwosu, et al.
Pageof 65

Showing results (471-480 of 650) with videos related to

Sort By:
Pageof 65
JAMA|February 24, 2016
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Mervyn Singer, Clifford S Deutschman, Christopher Warren Seymour, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Trials|April 7, 2019
The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trialDavid N Hager, Michael H Hooper, Gordon R Bernard, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2021
Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical TrialJonathan D Casey, Erin M Vaughan, Bradley D Lloyd, et al.
BMJ Open|May 5, 2018
Measuring outcome differences associated with STEMI screening and diagnostic performance: a multicentred retrospective cohort study protocolMaame Yaa A B Yiadom, Bryn E Mumma, Christopher W Baugh, et al.
Trials|December 6, 2019
Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trialChristopher J Lindsell, Anna McGlothlin, Samuel Nwosu, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Clinical Pharmacology and Therapeutics|May 17, 2012
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT projectJ M Pulley, J C Denny, J F Peterson, et al.
JAMA Internal Medicine|April 18, 2022
Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled TrialEdward Tang Qian, Cheryl L Gatto, Olga Amusina, et al.
Trials|April 23, 2020
In response: Letter on update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocolChristopher J Lindsell, Anna McGlothlin, Samuel Nwosu, et al.
Pageof 65